Ken Chin

Ken Chin is currently the Associate Director of CVRM Evidence Strategy at AstraZeneca. They have built a strong foundation in medical evidence and value strategy, previously holding positions as a Senior Consultant at IQVIA and a Clinical Epidemiologist at the University of Melbourne. Ken's academic background includes a PhD in Epidemiology from Monash University, complemented by a Master's in Clinical Pharmacy and a Bachelor's in Pharmacy from Universiti Sains Malaysia. They also contributed to ethical research practices as a Professional Member of the Human Research Ethics Committee at St Vincent's Hospital Melbourne.